Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Digital 9 repays credit facility after selling SeaEdge UK1

(Sharecast News) - Digital 9 Infrastructure announced on Wednesday that it has completed the sale of its SeaEdge UK1 asset to Stellium Datacenters for £10.7m, using the proceeds to fully repay and cancel its revolving credit facility. It said the sale price was broadly in line with the asset's year-end 2024 net asset value, and included deferred rent and associated receivables.

The London-listed firm said the transaction marked the conclusion of its stated realisation process, following the prior divestments of Verne Global in March and EMIC-1 in May.

Net proceeds from the SeaEdge sale amounted to £10.3m after costs, which, along with additional working capital, were used to repay the outstanding facility balance of £13m.

Digital 9 said it was focused on an orderly managed wind-down of the company, with a continued priority on returning capital to shareholders through further asset disposals and value optimisation of its remaining portfolio.

At 1059 BST, shares in Digital 9 Infrastructure were up 4.63% at 9.5p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.